Lucía Vanrell

563 total citations
20 papers, 453 citations indexed

About

Lucía Vanrell is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lucía Vanrell has authored 20 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lucía Vanrell's work include CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Virus-based gene therapy research (6 papers). Lucía Vanrell is often cited by papers focused on CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Virus-based gene therapy research (6 papers). Lucía Vanrell collaborates with scholars based in Spain, Uruguay and United States. Lucía Vanrell's co-authors include Gualberto González‐Sapienza, Andrés González‐Techera, Cristian Smerdou, Gloria González‐Aseguinolaza, Jesús Prìeto, Bruce D. Hammock, Pedro Berraondo, Stuart G. Beattie, Astrid Pañeda and Jerold A. Last and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Journal of Virology.

In The Last Decade

Lucía Vanrell

19 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucía Vanrell Spain 13 280 142 85 77 72 20 453
Cécile Artaud United States 14 358 1.3× 95 0.7× 88 1.0× 167 2.2× 55 0.8× 19 590
J K Räty Finland 9 419 1.5× 211 1.5× 101 1.2× 40 0.5× 63 0.9× 12 543
Sailan Shui Switzerland 9 234 0.8× 77 0.5× 30 0.4× 70 0.9× 111 1.5× 13 442
Dibyendu Samanta India 14 361 1.3× 73 0.5× 49 0.6× 185 2.4× 101 1.4× 36 587
Ryan McGuinness United States 11 280 1.0× 167 1.2× 64 0.8× 110 1.4× 127 1.8× 14 474
Lucia Le Roux United States 13 183 0.7× 73 0.5× 67 0.8× 25 0.3× 71 1.0× 24 422
Joseph Dukes United Kingdom 7 238 0.8× 46 0.3× 64 0.8× 145 1.9× 151 2.1× 13 547
Tuomas Huovinen Finland 11 391 1.4× 51 0.4× 146 1.7× 41 0.5× 39 0.5× 23 576
Bruno Gaillet Canada 12 395 1.4× 249 1.8× 41 0.5× 22 0.3× 82 1.1× 25 506
Kasandra Bélanger Canada 9 200 0.7× 36 0.3× 128 1.5× 89 1.2× 45 0.6× 15 387

Countries citing papers authored by Lucía Vanrell

Since Specialization
Citations

This map shows the geographic impact of Lucía Vanrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucía Vanrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucía Vanrell more than expected).

Fields of papers citing papers by Lucía Vanrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucía Vanrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucía Vanrell. The network helps show where Lucía Vanrell may publish in the future.

Co-authorship network of co-authors of Lucía Vanrell

This figure shows the co-authorship network connecting the top 25 collaborators of Lucía Vanrell. A scholar is included among the top collaborators of Lucía Vanrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucía Vanrell. Lucía Vanrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jáuregui, Patricia, Saray Rodríguez-Diaz, Rebeca Martínez-Turrillas, et al.. (2025). Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML. PubMed. 33(1). 200949–200949. 1 indexed citations
2.
Navarro, Rocío, Susana Frago, Laura Rubio‐Pérez, et al.. (2025). Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation. Frontiers in Immunology. 15. 1494206–1494206. 5 indexed citations
3.
Rubio‐Pérez, Laura, Susana Frago, Marta Compte, et al.. (2024). Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity. Antibodies. 13(2). 34–34. 3 indexed citations
4.
Igea, Ana, et al.. (2024). Targeting PD-1+ T cells with small-format immunocytokines enhances IL-12 antitumor activity. Molecular Therapy. 33(1). 297–316.
5.
Vanrell, Lucía, et al.. (2023). Checkpoint blockade meets gene therapy: Opportunities to improve response and reduce toxicity. International review of cell and molecular biology. 379. 43–86. 3 indexed citations
6.
Blanco, Ester, Teresa Lozano, Eva Martišová, et al.. (2023). Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses. Cancer Letters. 561. 216139–216139. 13 indexed citations
7.
Smerdou, Cristian, et al.. (2021). A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies. Microorganisms. 9(9). 1956–1956. 13 indexed citations
8.
Vanrell, Lucía, et al.. (2020). A new generation of vaccines based on alphavirus self-amplifying RNA. Current Opinion in Virology. 44. 145–153. 59 indexed citations
9.
Martišová, Eva, Sandra Hervás‐Stubbs, Noëlia Casares, et al.. (2020). Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity. Biomedicines. 8(12). 562–562. 17 indexed citations
10.
Vanrell, Lucía, Esperanza López‐Franco, Iria G. Dopeso‐Reyes, et al.. (2017). Adeno-Associated Viral Vectors Serotype 8 for Cell-Specific Delivery of Therapeutic Genes in the Central Nervous System. Frontiers in Neuroanatomy. 11. 2–2. 33 indexed citations
11.
Scala, Marianna Di, Itziar Otano, Irene Gil-Fariña, et al.. (2016). Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice. Journal of Virology. 90(19). 8563–8574. 16 indexed citations
12.
Scala, Marianna Di, Irene Gil-Fariña, Lucía Vanrell, et al.. (2015). Chronic exposure to IFN  drives medullar lymphopoiesis towards T cell differentiation in mice. Haematologica. 100(8). 1014–22. 8 indexed citations
13.
Rossotti, Martín A., et al.. (2014). Recombinant Streptavidin Nanopeptamer Anti-Immunocomplex Assay for Noncompetitive Detection of Small Analytes. Analytical Chemistry. 86(20). 10467–10473. 21 indexed citations
14.
Gil-Fariña, Irene, Marianna Di Scala, Lucía Vanrell, et al.. (2013). IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression. PLoS ONE. 8(7). e67748–e67748. 18 indexed citations
15.
Vanrell, Lucía, Andrés González‐Techera, Bruce D. Hammock, & Gualberto González‐Sapienza. (2012). Nanopeptamers for the Development of Small-Analyte Lateral Flow Tests with a Positive Readout. Analytical Chemistry. 85(2). 1177–1182. 29 indexed citations
16.
Vanrell, Lucía, Marianna Di Scala, Laura Blanco, et al.. (2011). Development of a Liver-specific Tet-On Inducible System for AAV Vectors and Its Application in the Treatment of Liver Cancer. Molecular Therapy. 19(7). 1245–1253. 50 indexed citations
17.
Unzu, Carmen, Ana Sampedro, Itsaso Mauleón, et al.. (2009). Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria. Journal of Hepatology. 52(3). 417–424. 23 indexed citations
18.
Pañeda, Astrid, Lucía Vanrell, Itsaso Mauleón, et al.. (2009). Effect of Adeno-Associated Virus Serotype and Genomic Structure on Liver Transduction and Biodistribution in Mice of Both Genders. Human Gene Therapy. 20(8). 908–917. 88 indexed citations
19.
González‐Techera, Andrés, Lucía Vanrell, Jerold A. Last, Bruce D. Hammock, & Gualberto González‐Sapienza. (2007). Phage Anti-Immune Complex Assay:  General Strategy for Noncompetitive Immunodetection of Small Molecules. Analytical Chemistry. 79(20). 7799–7806. 51 indexed citations
20.
Pañeda, Astrid, Lucía Vanrell, Rafael Enrı́quez de Salamanca, et al.. (2006). 1079. Effect of WPRE on Transgene Expression Using Different Promoters in the Context of Hydrodynamically Delivered Plasmid Vectors. Molecular Therapy. 13. S413–S414. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cécile Artaud Breakdown of academic impact, for papers by J K Räty Breakdown of academic impact, for papers by Sailan Shui Breakdown of academic impact, for papers by Dibyendu Samanta Breakdown of academic impact, for papers by Ryan McGuinness Breakdown of academic impact, for papers by Lucia Le Roux Breakdown of academic impact, for papers by Joseph Dukes Breakdown of academic impact, for papers by Tuomas Huovinen Breakdown of academic impact, for papers by Bruno Gaillet Breakdown of academic impact, for papers by Kasandra Bélanger
Rankless by CCL
2026